A therapeutic HIV-1 vaccine reduces markers of systemic immune activation and latent infection in patients under highly active antiretroviral therapy. - Pallikkuth S; Bolivar H; Fletcher MA; Babic DZ; De Armas LR; Gupta S; Termini JM; Arheart KL; Stevenson M; Tung FY; Fischl MA; Pahwa S; et al. (Vaccine, 2020)